Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Syed Naqvi

Concepts (45)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma
4
2024
279
0.600
Why?
Skin Neoplasms
4
2024
500
0.400
Why?
Chemotherapy, Cancer, Regional Perfusion
3
2024
10
0.330
Why?
Extremities
3
2024
32
0.320
Why?
Melphalan
2
2024
181
0.250
Why?
Dactinomycin
1
2024
23
0.230
Why?
Small Cell Lung Carcinoma
1
2024
30
0.220
Why?
Sarcoma
1
2024
70
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1031
0.210
Why?
Antibodies, Monoclonal, Humanized
1
2024
237
0.200
Why?
Oncolytic Virotherapy
1
2021
21
0.180
Why?
Antibodies, Monoclonal
1
2024
478
0.170
Why?
Lung Neoplasms
1
2024
634
0.150
Why?
Aged, 80 and over
5
2024
3420
0.150
Why?
Immunoglobulin Variable Region
1
2017
17
0.140
Why?
Immunoglobulin Heavy Chains
1
2017
46
0.140
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
59
0.130
Why?
Genomics
1
2017
270
0.120
Why?
Herpesvirus 1, Human
2
2024
17
0.100
Why?
Adult
6
2024
14170
0.100
Why?
Aged
5
2024
10191
0.090
Why?
Retrospective Studies
4
2024
6671
0.090
Why?
Mutation
1
2017
1344
0.090
Why?
Middle Aged
5
2024
13096
0.090
Why?
Neoplasm Staging
2
2024
768
0.080
Why?
Male
6
2024
26863
0.070
Why?
Neoplasm Recurrence, Local
2
2021
643
0.070
Why?
Prognosis
2
2024
2118
0.060
Why?
Female
5
2024
28262
0.060
Why?
Humans
7
2024
52593
0.060
Why?
Neoplasm Metastasis
1
2024
239
0.050
Why?
Young Adult
2
2024
4337
0.050
Why?
Survival Rate
1
2024
952
0.050
Why?
Watchful Waiting
1
2021
28
0.040
Why?
Australia
1
2020
90
0.040
Why?
Sentinel Lymph Node Biopsy
1
2021
118
0.040
Why?
Lymph Node Excision
1
2021
133
0.040
Why?
Immunotherapy
1
2021
244
0.040
Why?
Follow-Up Studies
1
2024
2291
0.040
Why?
Chromosomes, Human, Pair 12
1
2017
14
0.030
Why?
Karyotype
1
2017
19
0.030
Why?
Trisomy
1
2017
35
0.030
Why?
In Situ Hybridization, Fluorescence
1
2017
263
0.030
Why?
Survival Analysis
1
2017
673
0.030
Why?
United States
1
2020
5227
0.020
Why?
Naqvi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description